- Home
- ARTNA vs BNTC Comparison
ARTNA vs BNTC Comparison
Compare ARTNA & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTNA
- BNTC
- Stock Information
- Founded
- ARTNA 1905
- BNTC 1995
- Country
- ARTNA United States
- BNTC United States
- Employees
- ARTNA N/A
- BNTC N/A
- Industry
- ARTNA Water Supply
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- ARTNA Utilities
- BNTC Health Care
- Exchange
- ARTNA Nasdaq
- BNTC Nasdaq
- Market Cap
- ARTNA 343.5M
- BNTC 335.5M
- IPO Year
- ARTNA 1996
- BNTC N/A
- Fundamental
- Price
- ARTNA $33.15
- BNTC $13.24
- Analyst Decision
- ARTNA
- BNTC Strong Buy
- Analyst Count
- ARTNA 0
- BNTC 5
- Target Price
- ARTNA N/A
- BNTC $26.00
- AVG Volume (30 Days)
- ARTNA 28.6K
- BNTC 40.8K
- Earning Date
- ARTNA 08-04-2025
- BNTC 09-25-2025
- Dividend Yield
- ARTNA 3.71%
- BNTC N/A
- EPS Growth
- ARTNA 22.07
- BNTC N/A
- EPS
- ARTNA 2.17
- BNTC N/A
- Revenue
- ARTNA $110,427,000.00
- BNTC N/A
- Revenue This Year
- ARTNA $6.86
- BNTC N/A
- Revenue Next Year
- ARTNA $4.46
- BNTC N/A
- P/E Ratio
- ARTNA $15.28
- BNTC N/A
- Revenue Growth
- ARTNA 7.13
- BNTC N/A
- 52 Week Low
- ARTNA $29.45
- BNTC $8.06
- 52 Week High
- ARTNA $38.94
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- ARTNA 48.19
- BNTC 59.72
- Support Level
- ARTNA $33.00
- BNTC $12.57
- Resistance Level
- ARTNA $34.28
- BNTC $13.33
- Average True Range (ATR)
- ARTNA 0.66
- BNTC 0.60
- MACD
- ARTNA 0.01
- BNTC 0.10
- Stochastic Oscillator
- ARTNA 36.90
- BNTC 95.59
About ARTNA Artesian Resources Corporation
Artesian Resources Corp operates as a holding company with a focus on water distribution and wastewater services. Its regulated utility segment includes subsidiaries providing water and wastewater services in Delaware, Maryland, and Pennsylvania. Water distribution spans residential, commercial, industrial, and municipal sectors, while wastewater services are offered in Sussex County, Delaware. The company also engages in non-utility businesses, offering service line protection plans, engineering services, and contract operations for water and wastewater systems. The regulated utility segment constitutes the portion of the company's operations, subject to regulations by Delaware, Maryland, and Pennsylvania.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.